Company intelligence / Profile preview

Glanbia

Kilkenny, Kilkenny, Irelandglanbia.com ↗

Ownership: Public · GL9
Employees: ~5700
Development stage: Other

Overview

Glanbia is an active global leader specializing in performance nutrition products and functional food ingredients rather than pharmaceuticals or biotechnology therapeutics. Its core business includes supplying branded sports supplements/protein powders to consumers worldwide under names like Optimum Nutrition and BSN while also providing custom ingredient solutions to the broader food industry. The company's focus areas are general health/wellness through better dietary choices rather than disease-specific therapies or drug development pipelines.

Therapeutic areas: Other
Modalities: ProteinDairy proteinNutritional premixesFunctional ingredients
Industry: Food & Nutrition

Partnerships

Joint venture partner for US Cheese business

Financials

Market cap: $5.3B
Total revenue: $383.5M
Enterprise value: $8.3B

Beyond the preview

Go deeper on Glanbia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glanbia.

Explore the full profile